Silencing FUNDC1 alleviates chronic obstructive pulmonary disease by inhibiting mitochondrial autophagy and bronchial epithelium cell apoptosis under hypoxic environment

2019 ◽  
Vol 120 (10) ◽  
pp. 17602-17615 ◽  
Author(s):  
Wen Wen ◽  
Guoqing Yu ◽  
Wei Liu ◽  
Lei Gu ◽  
Jiahui Chu ◽  
...  
2017 ◽  
Vol 124 ◽  
pp. 72-78 ◽  
Author(s):  
Sayantan Datta ◽  
Hae-Seong Nam ◽  
Masamichi Hayashi ◽  
Leonel Maldonado ◽  
Rachel Goldberg ◽  
...  

2019 ◽  
Vol 126 (1) ◽  
pp. 67-76 ◽  
Author(s):  
James P. Hummel ◽  
Martin L. Mayse ◽  
Steve Dimmer ◽  
Philip J. Johnson

Parasympathetic efferent innervation of the lung is the primary source of lung acetylcholine. Inhaled long-acting anticholinergics improve lung function and symptoms in patients with chronic obstructive pulmonary disease. Targeted lung denervation (TLD), a bronchoscopic procedure intended to disrupt pulmonary parasympathetic inputs, is an experimental treatment for chronic obstructive pulmonary disease. The physiologic and histologic effects of TLD have not previously been assessed. Eleven sheep and two dogs underwent circumferential ablation of the main bronchi with simultaneous balloon surface cooling using a lung denervation system (Nuvaira, Inc., Minneapolis, MN). Changes in pulmonary air flow resistance were monitored before and following TLD. Four animals were assessed for the presence or abolishment of the sensory axon-mediated Hering-Breuer reflex before and following TLD. Six sheep were histologically evaluated 30 days post-TLD for the extent of lung denervation (axonal staining) and effect on peribronchial structures near the treatment site. No adverse clinical effects were seen in any treated animals. TLD produced a ~30% reduction in pulmonary resistance and abolished the sensory-mediated Hering-Breuer reflex. Axonal staining was consistently decreased 60% at 30 days after TLD. All treated airways exhibited 100% epithelial integrity. Damage to other peribronchial structures was minimal. Tissue 1 cm proximal and distal to the treatment was normal, and the esophagus and periesophageal vagus nerve branches were unaffected. TLD treatment effectively denervates the lung while protecting the bronchial epithelium and minimizing effects on peribronchial structures. NEW & NOTEWORTHY The feasibility of targeted lung denervation, a new minimally invasive therapy for obstructive lung disease, has been demonstrated in humans with preliminary clinical studies demonstrating improvement in symptoms, pulmonary function, and exercise capacity in patients with chronic obstructive pulmonary disease. This preclinical animal study demonstrates the ability of targeted lung denervation to disrupt vagal inputs to the lung and details its physiologic and histopathologic effects.


1998 ◽  
Vol 92 (6) ◽  
pp. 863-870 ◽  
Author(s):  
A. Pesci ◽  
M. Majori ◽  
A. Cuomo ◽  
N. Borciani ◽  
S. Bertacco ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (5) ◽  
pp. e0156009 ◽  
Author(s):  
Helen M. Rigden ◽  
Ahmad Alias ◽  
Thomas Havelock ◽  
Rory O'Donnell ◽  
Ratko Djukanovic ◽  
...  

2020 ◽  
Vol 8 (12) ◽  
pp. 6357-6366
Author(s):  
Li Wang ◽  
Yan Tan ◽  
Lin Gao ◽  
Jing Lei ◽  
Chen Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document